Drug Profile
GS 9160
Latest Information Update: 21 Apr 2008
Price :
$50
*
At a glance
- Originator Gilead Sciences
- Class
- Mechanism of Action HIV integrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 15 Jun 2006 Phase-I clinical trials in HIV infections in USA (unspecified route)